APA引文

Mullin, K., Kudrow, D., Croop, R., Lovegren, M., Conway, C. M., Coric, V., & Lipton, R. B. (2020). Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy. Neurology.

Citação norma Chicago

Mullin, Kathleen, David Kudrow, Robert Croop, Meghan Lovegren, Charles M. Conway, Vladimir Coric, and Richard B. Lipton. "Potential for Treatment Benefit of Small Molecule CGRP Receptor Antagonist Plus Monoclonal Antibody in Migraine Therapy." Neurology 2020.

MLA引文

Mullin, Kathleen, et al. "Potential for Treatment Benefit of Small Molecule CGRP Receptor Antagonist Plus Monoclonal Antibody in Migraine Therapy." Neurology 2020.